COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Reviva Pharmaceuticals is a clinical-stage biotech developing internally discovered therapies for CNS, metabolic, and cardiopulmonary diseases; lead candidate RP5063 modulates dopamine/serotonin receptors and targets schizophrenia and PAH.
Focus Areas
Total Raised
Funding round